Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracey M Farragher

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Arthritis Care & Research|May 13, 2010
Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodiesTracey M Farragher, Mark Lunt, Darren Plant, et al.
Arthritis and Rheumatism|April 3, 2008
The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritisSophia M Naz, Tracey M Farragher, Diane K Bunn, et al.
Arthritis Care & Research|May 13, 2010
Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patientsTracey M Farragher, Darren Plant, Edward Flynn, et al.
Arthritis and Rheumatism|February 2, 2008
Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritisTracey M Farragher, Nicola J Goodson, Haris Naseem, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritisJarrod Franklin, Tracey M Farragher, Mark Lunt, et al.
Rheumatology (Oxford, England)|December 25, 2009
Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics RegisterPaul A C Lord, Tracey M Farragher, Mark Lunt, et al.
Arthritis and Rheumatism|October 1, 2009
Association of functional outcome with both personal- and area-level socioeconomic inequalities in patients with inflammatory polyarthritisMark J Harrison, Tracey M Farragher, Alexandra M Clarke, et al.
Drug Safety|June 28, 2015
Prevalence, Nature, Severity and Risk Factors for Prescribing Errors in Hospital Inpatients: Prospective Study in 20 UK HospitalsDarren M Ashcroft, Penny J Lewis, Mary P Tully, et al.
Arthritis Research & Therapy|October 1, 2011
Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational studyHoda Mirjafari, Tracey M Farragher, Suzanne M M Verstappen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 29, 2009
Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification systemMark J Harrison, Linda M Davies, Nick J Bansback, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Arthritis Care & Research|May 13, 2010
Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodiesTracey M Farragher, Mark Lunt, Darren Plant, et al.
Arthritis and Rheumatism|April 3, 2008
The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritisSophia M Naz, Tracey M Farragher, Diane K Bunn, et al.
Arthritis Care & Research|May 13, 2010
Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patientsTracey M Farragher, Darren Plant, Edward Flynn, et al.
Arthritis and Rheumatism|February 2, 2008
Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritisTracey M Farragher, Nicola J Goodson, Haris Naseem, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritisJarrod Franklin, Tracey M Farragher, Mark Lunt, et al.
Rheumatology (Oxford, England)|December 25, 2009
Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics RegisterPaul A C Lord, Tracey M Farragher, Mark Lunt, et al.
Arthritis and Rheumatism|October 1, 2009
Association of functional outcome with both personal- and area-level socioeconomic inequalities in patients with inflammatory polyarthritisMark J Harrison, Tracey M Farragher, Alexandra M Clarke, et al.
Drug Safety|June 28, 2015
Prevalence, Nature, Severity and Risk Factors for Prescribing Errors in Hospital Inpatients: Prospective Study in 20 UK HospitalsDarren M Ashcroft, Penny J Lewis, Mary P Tully, et al.
Arthritis Research & Therapy|October 1, 2011
Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational studyHoda Mirjafari, Tracey M Farragher, Suzanne M M Verstappen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 29, 2009
Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification systemMark J Harrison, Linda M Davies, Nick J Bansback, et al.
Pageof 2